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Abstract 24 
Horizontally acquired genes can be costly to express even if they encode useful traits, such 25 
as antibiotic resistance. We previously showed that when selected with tetracycline, 26 
Escherichia coli carrying the tetracycline resistance plasmid RK2 evolved mutations on both 27 
replicons that together provided increased tetracycline resistance at reduced cost. Here we 28 
investigate the temporal dynamics of this intragenomic coevolution. Using genome 29 
sequencing we show that the order of adaptive mutations was highly repeatable across 30 
three independently evolving populations. Each population first gained a chromosomal 31 
mutation in ompF which shortened lag phase and increased tetracycline resistance. This 32 
was followed by mutations impairing the plasmid-encoded tetracycline efflux pump, and 33 
lastly, additional resistance-associated chromosomal mutations. Thus, reducing the cost of 34 
the horizontally-acquired tetracycline resistance was contingent on first evolving a degree of 35 
chromosomally-encoded resistance. We conclude therefore that the trajectory of bacteria-36 
plasmid coevolution was constrained to a single repeatable path. 37 
 38 
Main 39 
The acquisition of mobile genetic elements (MGEs) encoding ecologically important 40 
functions promotes evolutionary innovation in bacteria [1]. The rapid spread of antibiotic 41 
resistance among bacterial pathogens is facilitated by the horizontal gene transfer (HGT) of 42 
multidrug resistance (MDR) plasmids [2, 3]. However, MDR plasmid acquisition is often 43 
costly for the host cell leading to conflict between the chromosome and the plasmid [4, 5]. 44 
These conflicts, which may arise through disruption of host cellular networks or cytotoxicity 45 
of plasmid encoded proteins [6], can be ameliorated through compensatory evolution to 46 
reduce the cost of plasmid carriage, and, in some cases, reciprocal co-adaptation of the 47 
chromosomal and plasmid replicons [7, 8]. We previously showed that when selected with 48 
tetracycline, Escherichia coli carrying the tetracycline resistance plasmid RK2 evolved 49 
mutations on both replicons that together provided increased tetracycline resistance at 50 
reduced cost [7]. In the previous study we confirmed for a single population that the 51 
 3 
emergence of chromosomal resistance preceded mutation of the plasmid, but were unable 52 
to test the repeatability of this coevolutionary trajectory between multiple independent 53 
populations. Here we investigate the temporal dynamics of intragenomic coevolution by 54 
whole genome sequencing 27 additional evolved clones isolated through time from three 55 
independently evolving populations selected with tetracycline.  56 
 57 
Three clones from transfers 8,16, and 40 from three independent populations under 58 
tetracycline treatment were newly sequenced. These together with the previously published 59 
genomes from transfer 80 [7] were analysed to assess the order of mutations within each 60 
population. Construction of phylogenies based on the presence or absence of mutations 61 
shows that there was considerable within-population diversity across all three populations 62 
(Fig. 1, for methods see Supplementary Information). The accumulation of short branches at 63 
the base of the trees suggests divergence during the early stages of evolution. 64 
Subsequently, a single lineage appears to dominate population T4, arising early within the 65 
experiment, suggestive of the stepwise acquisition of beneficial mutations with subsequent 66 
selective sweeps within this lineage. Likewise, in population AT2 a single lineage dominated 67 
by transfer 16 but was superseded by a second lineage that appears to have diverged 68 
earlier in time. Whereas, in population AT5 the phylogeny has deeper branching, indicating 69 
that different mutations emerged in parallel and lineages coexisted for a longer duration than 70 
observed in the T4 or AT2.  71 
 72 
In the original study a single clone was sequenced from the end point transfer (transfer 80) 73 
from each population. Adaptive mutations were identified as those showing parallel evolution 74 
in multiple replicate populations within tetracycline treatments, which is strong evidence that 75 
mutations at these loci were the targets of natural selection [7]. Hereafter we focus our 76 
analysis on this subset of mutated loci. Across all three populations, the order in which these 77 
parallel mutations were acquired was shared. The first parallel mutation gained was the loss 78 
of function of the outer membrane porin ompF via the acquisition of an IS element at transfer 79 
 4 
16 (Fig. 2). Many classes of antibiotics, including tetracycline, cross the outer membrane of 80 
gram-negative bacteria via outer membrane porin proteins including OmpF [9, 10]. Loss of 81 
function of the ompF gene reduces membrane permeability and is associated with 82 
resistance phenotypes in clinical isolates of E. coli [11]. Clones isolated from transfer 16 had 83 
significantly increased resistance to tetracycline when compared to those from transfer 8 or 84 
the ancestral strain (Fig. 1 and Fig. S3, Post-hoc Tukey Tests: Anc(RK2):Transfer 16 all p < 85 
0.05, see Table S2 for ANOVA tables), and this was significantly associated with mutation of 86 
ompF (Pearson Chi-squared, χ2 = 30, p < 0.01, Bonferroni corrected). By transfer 16 all 87 
clones also had a significantly reduced lag phase compared to the ancestral strain (Fig. S4, 88 
Post-hoc Tukey Tests: Anc(RK2):Transfer 16 all p < 0.05, see Table S3 for ANOVA tables). 89 
IS elements were observed within all subsequent time points, however, only population T4 90 
maintained the same IS element within ompF throughout the experiment. Populations AT2 91 
and AT5 had multiple different IS elements within the ompF loci (Fig. 2). These results 92 
suggest that the loss of function of OmpF could evolve independently multiple times within a 93 
single population. Similar MIC values among these independent lineages suggest that these 94 
mutations had equivalent functional consequences (Fig. S3). 95 
 96 
Non-synonymous single nucleotide polymorphisms (SNP) within the plasmid-encoded tetA 97 
or tetR genes, the tetracycline specific efflux pump and its negative regulator genes 98 
respectively, [12] were the next parallel mutations observed (Fig. 2). These mutations 99 
reduce the cost of the plasmid, but cause weaker resistance to tetracycline, in the ancestral 100 
MG1665 [7]. There was no significant difference in the MIC between clones from transfer 16 101 
and 40 (Post-hoc Tukey Tests: Transfer 16:Transfer 40 p > 0.05), suggesting that ompF 102 
mutations compensated for the reduced resistance provided by the mutated tetracycline 103 
efflux pump [7]. 104 
 105 
Mutations in the hypothetical general stress response gene, ychH [13], were the next parallel 106 
mutations observed (Fig. 2) followed by mutation of acrR, encoding the negative regulator of 107 
 5 
the acrAB MDR cassette [14]. Mutation of acrR causes overexpression of the AcrAB-TolC 108 
multidrug efflux pump, leading to MDR phenotypes [15, 16]. Genetically different mutations, 109 
including premature stop codons and acquisition of IS elements within ychH and acrR, 110 
occurred within multiple lineages of the same population (Fig. 2). However, the acquisition of 111 
these secondary resistance-associated mutations was not associated with resistance 112 
(Pearson Chi-squared, ychH χ2 = 3.91, p > 0.05, acrR χ2 = 2.14, p > 0.05, Bonferroni 113 
corrected), providing no increase in tetracycline MIC (Post-hoc Tukey Tests, populations T4 114 
and AT5: Transfer 16:Transfer 40:Transfer 80 all p > 0.05; Fig S3). In contrast, the endpoint 115 
clone isolated from the AT2 population lacked mutations in either gene but showed reduced 116 
tetracycline resistance (Fig. S3, not significantly different from ancestral MIC, Anc(RK2):AT2 117 
Transfer 80 p = 0.481).  118 
 119 
We have shown that chromosome-plasmid coevolution under antibiotic selection was highly 120 
repeatable between three independently evolving populations. Similarly, within these 121 
populations, multiple lineages arose which acquired genetically distinct but functionally 122 
equivalent mutations in the same order, further emphasising how strikingly repeatable the 123 
observed bacteria-plasmid coevolution was.  Mutations in a chromosomally-encoded outer 124 
membrane porin increasing tetracycline resistance and reducing lag phase were followed by 125 
mutations impairing the costly plasmid-encoded tetracycline efflux pump [17, 18], and 126 
subsequent mutation of chromosomally-encoded stress response and multidrug efflux 127 
systems. The phenotypic effects upon resistance and growth potentially govern the 128 
repeatable order of mutations, suggesting that reducing the cost of expressing the 129 
horizontally-acquired tetracycline resistance was contingent on first evolving a degree of 130 
chromosomally-encoded resistance. The earliest mutation, ompF, had the greatest 131 
phenotypic effect on both tetracycline resistance and growth possibly suggesting a role for 132 
diminishing returns epistasis in the order that mutations were selected [19]. The fitness 133 
landscape of antibiotic resistance mutations can constrain the order in which resistance 134 
mutations are acquired [20], giving rise in both experimental [21] and clinical [22, 23] studies 135 
 6 
to strikingly predictable trajectories of antibiotic resistance evolution. Here we show that the 136 
trajectory chromosome-plasmid coevolution under antibiotic selection is similarly highly 137 
predictable, which may contribute to our understanding of successful pathogenic clades 138 
following their acquisition of MDR plasmids [24, 25]. Our data highlight the importance of 139 
coevolution for the continued evolutionary adaptation of resistant strains under antibiotic 140 
selection.  141 
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Fig. 1 Phylogeny of sequenced clones isolated from populations T4, AT2 and AT5 rooted 226 
using the ancestral MG1655(RK2). The distance matrix used to produce the tree was 227 
constructed from the binary presence or absence of mutations, specific to the nucleotide 228 
level, relative to the ancestral strain. The scale bar represents number of mutations. Branch 229 
tips are coloured by the MIC of the sequenced clone, tip symbols represent the presence of 230 
parallel mutations within the evolved clone. Tips are labelled with the transfer from which the 231 
clone was isolated from. Blue branches show the lineage of clone evolved within the 232 
tetracycline only treatment, purple branches show two independent populations evolved 233 
under tetracycline plus ampicillin treatment. MIC curves for each transfer are presented in 234 
Fig. S4. Full genotypes of sequenced strains are available in Table S1. 235 
 10 
 236 
Fig. 2 Genomic changes observed at transfers 8, 16, 40 and 80 within populations under 237 
tetracycline treatment. Concentric rings represent E. coli chromosomes or RK2 plasmids, 238 
ring colour represent the time point the clones were isolated (see keys); inner lighter rings to 239 
outer darker rings represent progression through time. Sets of three concentric rings are 240 
representative of three independent clones isolated from the same time-point within the 241 
populations. Points on the plot represent mutations at specific loci, circles = non-242 
synonymous mutations, bars = deletions, squares = duplications, and triangles = IS 243 
elements (colours show type of IS element, see key). Genome sequences from transfer 80 244 
are previously published in [7]. 245 
 246 
